The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
David Squires delivers a brilliant cartoon commentary on football's soul being consumed by commercialism, featuring the ominous arrival of 'George of the Generic' and the sport's worrying future direction.
Exclusive investigation reveals rising substance abuse at British weddings, from cocaine in bathrooms to MDMA on dance floors. Discover the highs, lows and sobering reality.
World Anti-Doping Agency president issues stark warning against proposed Enhanced Games, calling them 'dangerous' and demanding immediate action to prevent their launch.
Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.